| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Serves as an ovarian cancer RNA biomarker for liquid biopsy detection; expression increases in OC cell lines and clinical blood samples and helps distinguish early and advanced stages of OC. |
| Molecular mechanism: |
No disease functional mechanism was investigated; the study used MIRACLE SlipChip with BstNI-directed circRNA back-splice junction identification, RCA amplification, and CRISPR/Cas12a fluorescence detection for biomarker quantification. |
| Biological pathway or process: |
not specified |
| Detected method: |
Q
M
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Clinical Sample Validation; ROC Analysis |
| Clinical significance: |
hsa_circ_0049101 is a diagnostic RNA biomarker for ovarian cancer liquid biopsy, with AUC 0.985 for all-stage OC and AUC 0.969 for early-stage OC in the MIRACLE SlipChip assay. |
| Description: |
This study evaluated hsa_circ_0049101/circMUC16 as an ovarian cancer liquid biopsy biomarker rather than as a mechanistic regulator. Its expression was higher in OC cell lines and clinical blood samples, increased with disease stage, correlated strongly with RT-qPCR measurements, and showed high diagnostic performance for both all-stage and early-stage OC. |
| Confidence score: |
0.5261 |